プロモーションスケジュール Intensity Therapeutics, Inc.
詳細なスケジュール
簡易グラフ
会社について
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.
| EBITDA |
-0.0057 |
| EV/EBITDA |
0.6288 |
| IPO date |
2023-06-30 |
| ISIN |
US45828J1034 |
| Industry |
Biotechnology |
| P/BV |
5.61 |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
usd |
| Сайт |
https://intensitytherapeutics.com
|
| Цена ао |
5.33 |
| Число акций ао |
0.00862 млрд |
| 1日あたりの価格変動: |
+3.68% (1.9) |
| 週ごとの価格変動: |
+4.79% (1.88) |
| 月ごとの料金変更: |
-29.33% (2.7875) |
| 3ヶ月間の価格変動: |
-48.56% (3.83) |
| 半年間の価格変動: |
-59.55% (4.87) |
| 年間の価格変動: |
-77.01% (8.57) |
| 3年間の価格推移: |
0% (1.97) |
| 5年間の価格推移: |
0% (1.97) |
| 10年間の価格推移: |
0% (1.97) |
| 年初からの価格変動: |
-3.19% (2.035) |
|
|
過小評価
| 名前 |
意味 |
学年 |
| P/S |
0 |
0 |
| P/BV |
4.17 |
4 |
| P/E |
0 |
0 |
| EV/EBITDA |
-5.69 |
0 |
| 合計: |
|
2.75 |
|
効率
| 名前 |
意味 |
学年 |
| ROA, % |
-60.93 |
0 |
| ROE, % |
-80.06 |
0 |
| 合計: |
|
0 |
|
|
|
配当金
| 名前 |
意味 |
学年 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 合計: |
|
0 |
|
義務
| 名前 |
意味 |
学年 |
| Debt/EBITDA |
-0.0193 |
10 |
| 合計: |
|
9.6 |
|
成長の衝動
| 名前 |
意味 |
学年 |
| 収益性 Revenue, % |
0 |
0 |
| 収益性 Ebitda, % |
76.95 |
8 |
| 収益性 EPS, % |
311.52 |
10 |
| 合計: |
|
7.2 |
|
| スーパーバイザー |
役職 |
支払い |
生年 |
| Mr. Lewis H. Bender M.A., M.B.A., M.S. |
Founder, President, CEO & Chairman of the Board |
1.1M |
1959 (66 年) |
| Mr. John Wesolowski CPA, M.B.A. |
Principal Accounting Officer & Controller |
272.37k |
1960 (65 年) |
| Mr. James M. Ahlers |
Executive Vice President of Corporate Finance |
75.09k |
1964 (61 年) |
| Mr. Brian Schwartz M.D. |
Executive Vice President of Clinical Development |
N/A |
|
| Mr. Joseph Talamo CPA, M.B.A. |
Chief Financial Officer |
N/A |
1969 (56 年) |
